# Occidental Petroleum Corp: financial statements, quarterly

OXY · NYSE · CIK 797468 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oxy.md) · [Financials](/companies/oxy/financials.md) · [Filings](/companies/oxy/filings.md) · [Insiders](/companies/oxy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oxy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7,271](/filings/0000797468-24-000164.md) | [2,243 d](/filings/0001628280-26-009059.md) | [6,731](/filings/0000797468-25-000076.md) | [6,802](/filings/0000797468-25-000111.md) | [7,020](/filings/0001628280-25-051071.md) | [2,157 d](/filings/0001628280-26-009059.md) | [5,813](/filings/0001628280-26-030584.md) | [5,163](/filings/0001628280-26-053388.md) | [6,682](/filings/0001628280-25-051071.md) | [1,658 d](/filings/0001628280-26-009059.md) | [5,569](/filings/0001628280-26-030584.md) | [7,053](/filings/0001628280-26-053388.md) |
| Cost of revenue | $m | [682](/filings/0000797468-24-000164.md) | [898 d](/filings/0000797468-25-000029.md) | [828](/filings/0000797468-25-000076.md) | [910](/filings/0000797468-25-000111.md) | [889](/filings/0001628280-25-051071.md) | [494 d](/filings/0000797468-25-000029.md) | [801](/filings/0000797468-25-000076.md) | [847](/filings/0000797468-25-000111.md) | [812](/filings/0001628280-25-051071.md) | not reported | not reported | not reported |
| Selling, general and administrative | $m | [258](/filings/0000797468-24-000164.md) | [211 d](/filings/0001628280-26-009059.md) | [259](/filings/0000797468-25-000076.md) | [259](/filings/0000797468-25-000111.md) | [268](/filings/0001628280-25-051071.md) | [174 d](/filings/0001628280-26-009059.md) | [241](/filings/0001628280-26-030584.md) | [257](/filings/0001628280-26-053388.md) | [277](/filings/0001628280-25-051071.md) | [158 d](/filings/0001628280-26-009059.md) | [245](/filings/0001628280-26-030584.md) | [262](/filings/0001628280-26-053388.md) |
| Income tax | $m | [434](/filings/0000797468-24-000164.md) | [(42.0) d](/filings/0001628280-26-009059.md) | [304](/filings/0000797468-25-000076.md) | [465](/filings/0000797468-25-000111.md) | [454](/filings/0001628280-25-051071.md) | [(65.0) d](/filings/0001628280-26-009059.md) | [347](/filings/0001628280-26-030584.md) | [222](/filings/0001628280-26-053388.md) | [324](/filings/0001628280-25-051071.md) | [40.0 d](/filings/0001628280-26-009059.md) | [154](/filings/0001628280-26-030584.md) | [915](/filings/0001628280-26-053388.md) |
| Net income | $m | [1,375](/filings/0000797468-23-000092.md) | [1,198 d](/filings/0000797468-24-000034.md) | [888](/filings/0000797468-24-000095.md) | [1,170](/filings/0000797468-25-000111.md) | [1,140](/filings/0001628280-25-051071.md) | [(120) d](/filings/0001628280-26-009059.md) | [945](/filings/0001628280-26-030584.md) | [468](/filings/0001628280-26-053388.md) | [842](/filings/0001628280-25-051071.md) | [114 d](/filings/0001628280-26-009059.md) | [3,359](/filings/0001628280-26-030584.md) | [2,996](/filings/0001628280-26-053388.md) |
| Diluted EPS | $ per share | [1.20](/filings/0000797468-24-000164.md) | not reported | [0.75](/filings/0000797468-25-000076.md) | [1.03](/filings/0000797468-25-000111.md) | [0.98](/filings/0001628280-25-051071.md) | not reported | [0.77](/filings/0001628280-26-030584.md) | [0.26](/filings/0001628280-26-053388.md) | [0.65](/filings/0001628280-25-051071.md) | not reported | [3.13](/filings/0001628280-26-030584.md) | [2.75](/filings/0001628280-26-053388.md) |
| Basic EPS | $ per share | [1.30](/filings/0000797468-24-000164.md) | not reported | [0.81](/filings/0000797468-25-000076.md) | [1.10](/filings/0000797468-25-000111.md) | [1.03](/filings/0001628280-25-051071.md) | not reported | [0.81](/filings/0001628280-26-030584.md) | [0.27](/filings/0001628280-26-053388.md) | [0.67](/filings/0001628280-25-051071.md) | not reported | [3.19](/filings/0001628280-26-030584.md) | [2.80](/filings/0001628280-26-053388.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000797468-24-000164.md) | [1.4](/filings/0000797468-25-000029.md) | [1.3](/filings/0000797468-25-000076.md) | [1.8](/filings/0000797468-25-000111.md) | [1.8](/filings/0001628280-25-051071.md) | [2.1](/filings/0001628280-26-009059.md) | [2.6](/filings/0001628280-26-030584.md) | [2.3](/filings/0001628280-26-053388.md) | [2.2](/filings/0001628280-25-051071.md) | [2.0](/filings/0001628280-26-053388.md) | [3.8](/filings/0001628280-26-030584.md) | [4.2](/filings/0001628280-26-053388.md) |
| Current assets | $bn | [8.3](/filings/0000797468-23-000092.md) | [8.4](/filings/0000797468-25-000029.md) | [8.3](/filings/0000797468-24-000095.md) | [10.1](/filings/0000797468-24-000136.md) | [9.6](/filings/0000797468-24-000164.md) | [9.1](/filings/0001628280-26-009059.md) | [9.7](/filings/0000797468-25-000076.md) | [9.0](/filings/0000797468-25-000111.md) | [8.8](/filings/0001628280-25-051071.md) | [8.8](/filings/0001628280-26-053388.md) | [11.1](/filings/0001628280-26-030584.md) | [11.1](/filings/0001628280-26-053388.md) |
| Total assets | $bn | [71.8](/filings/0000797468-23-000092.md) | [74.0](/filings/0000797468-25-000029.md) | [74.3](/filings/0000797468-25-000076.md) | [76.2](/filings/0000797468-25-000111.md) | [85.8](/filings/0001628280-25-051071.md) | [85.4](/filings/0001628280-26-009059.md) | [85.0](/filings/0000797468-25-000076.md) | [84.4](/filings/0000797468-25-000111.md) | [83.5](/filings/0001628280-25-051071.md) | [84.2](/filings/0001628280-26-053388.md) | [80.5](/filings/0001628280-26-030584.md) | [80.4](/filings/0001628280-26-053388.md) |
| Current liabilities | $bn | [8.9](/filings/0000797468-23-000092.md) | [9.1](/filings/0000797468-25-000029.md) | [8.8](/filings/0000797468-24-000095.md) | [9.7](/filings/0000797468-24-000136.md) | [9.5](/filings/0000797468-24-000164.md) | [9.5](/filings/0001628280-26-009059.md) | [9.6](/filings/0000797468-25-000076.md) | [8.6](/filings/0000797468-25-000111.md) | [9.4](/filings/0001628280-25-051071.md) | [9.4](/filings/0001628280-26-053388.md) | [9.2](/filings/0001628280-26-030584.md) | [7.9](/filings/0001628280-26-053388.md) |
| Long-term debt | $bn | [18.6](/filings/0000797468-23-000092.md) | [18.5](/filings/0000797468-24-000164.md) | [18.5](/filings/0000797468-24-000095.md) | [18.4](/filings/0000797468-24-000136.md) | [25.5](/filings/0000797468-24-000164.md) | [25.0](/filings/0001628280-25-051071.md) | [24.0](/filings/0000797468-25-000076.md) | [23.3](/filings/0000797468-25-000111.md) | [20.8](/filings/0001628280-25-051071.md) | [20.6](/filings/0001628280-26-053388.md) | [15.2](/filings/0001628280-26-030584.md) | [13.5](/filings/0001628280-26-053388.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | [1.2](/filings/0000797468-24-000136.md) | [1.0](/filings/0000797468-24-000164.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [29.3](/filings/0000797468-24-000164.md) | [30.3](/filings/0000797468-25-000029.md) | [30.8](/filings/0000797468-24-000095.md) | [32.1](/filings/0000797468-24-000136.md) | [34.7](/filings/0000797468-24-000164.md) | [34.2](/filings/0001628280-26-009059.md) | [34.7](/filings/0000797468-25-000076.md) | [35.7](/filings/0000797468-25-000111.md) | [36.3](/filings/0001628280-25-051071.md) | [36.0](/filings/0001628280-26-053388.md) | [38.9](/filings/0001628280-26-030584.md) | [41.7](/filings/0001628280-26-053388.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,129 d](/filings/0000797468-24-000164.md) | [3,239 d](/filings/0001628280-26-009059.md) | [2,007](/filings/0000797468-25-000076.md) | [2,394 d](/filings/0000797468-25-000111.md) | [3,682 d](/filings/0001628280-25-051071.md) | [3,356 d](/filings/0001628280-26-009059.md) | [2,148](/filings/0001628280-26-030584.md) | [2,960 d](/filings/0001628280-26-053388.md) | [2,790 d](/filings/0001628280-25-051071.md) | [2,634 d](/filings/0001628280-26-009059.md) | [1,281](/filings/0001628280-26-030584.md) | [4,271 d](/filings/0001628280-26-053388.md) |
| Capital expenditure | $m | [1,619 d](/filings/0000797468-24-000164.md) | [970 d](/filings/0001628280-26-009059.md) | [1,783](/filings/0000797468-25-000076.md) | [1,771 d](/filings/0000797468-25-000111.md) | [1,683 d](/filings/0001628280-25-051071.md) | [1,026 d](/filings/0001628280-26-009059.md) | [1,682](/filings/0001628280-26-030584.md) | [1,705 d](/filings/0001628280-26-053388.md) | [2,287 d](/filings/0001628280-25-051071.md) | [753 d](/filings/0001628280-26-009059.md) | [1,554](/filings/0001628280-26-030584.md) | [1,589 d](/filings/0001628280-26-053388.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [434 d](/filings/0000797468-24-000164.md) | [187 d](/filings/0001628280-26-009059.md) | [0.0](/filings/0000797468-24-000095.md) | [9.0 d](/filings/0000797468-25-000111.md) | [0.0 d](/filings/0001628280-25-051071.md) | [18.0 d](/filings/0001628280-26-009059.md) | [0.0](/filings/0001628280-26-030584.md) | [0.0 d](/filings/0001628280-26-053388.md) | [0.0 d](/filings/0001628280-25-051071.md) | [0.0 d](/filings/0001628280-26-009059.md) | [56.0](/filings/0001628280-26-030584.md) | [61.0 d](/filings/0001628280-26-053388.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,003](/filings/0000797468-23-000092.md) | [975](/filings/0000797468-24-000095.md) | [959](/filings/0000797468-24-000136.md) | [958](/filings/0000797468-24-000164.md) | [949](/filings/0000797468-25-000076.md) | [959](/filings/0000797468-25-000111.md) | [976](/filings/0001628280-25-051071.md) | [983](/filings/0001628280-26-030584.md) | [1,010](/filings/0001628280-26-053388.md) | [1,003](/filings/0001628280-25-051071.md) | [1,007](/filings/0001628280-26-030584.md) | [1,012](/filings/0001628280-26-053388.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 999,637,371 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053388.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.